Chitosan-Based Nanoparticles for Targeted Nasal Galantamine Delivery as a Promising Tool in Alzheimer's Disease Therapy

• Главные авторы: Dilyana Georgieva (Автор), Denitsa Nikolova (Автор), Elena Vassileva (Автор), Bistra Kostova (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2023-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Natural alkaloid galantamine is widely used for the treatment of mild to moderate Alzheimer's dementia. Galantamine hydrobromide (GH) is available as fast-release tablets, extended-release capsules, and oral solutions. However, its oral delivery can cause some unwanted side effects, such as gas...